fda pulls semaglutide Approves Oral Semaglutide: First GLP-1 Pill for Weight Loss FDA Ban on Compounded GLP-1

Standard semaglutide, commonly sold as brand names like Ozempic or Wegovy, comes in a pre-filled injection pen designed to treat type 2 diabetes and assist with weight loss

Xeomin is a purified wrinkle relaxer commonly used to treat forehead lines, frown lines, and crows feet

Pediatric Exclusivity: The Six-Month Bonus Round Pediatric exclusivity adds six months to any existing patents and regulatory exclusivity periods when a sponsor completes FDA-requested pediatric studies under the Best Pharmaceuticals for Children Act [3]

5 Limitations and future directions of research Given the scope of the present study, several key factors warrant acknowledgment: First, bridging the translational gap between animal models and human clinical applications is challenging